Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

431 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Decreased liver B vitamin-related enzymes as a metabolic hallmark of cancer cachexia.
Kojima Y, Mishiro-Sato E, Fujishita T, Satoh K, Kajino-Sakamoto R, Oze I, Nozawa K, Narita Y, Ogata T, Matsuo K, Muro K, Taketo MM, Soga T, Aoki M. Kojima Y, et al. Among authors: nozawa k. Nat Commun. 2023 Oct 6;14(1):6246. doi: 10.1038/s41467-023-41952-w. Nat Commun. 2023. PMID: 37803016 Free PMC article.
Impact of omitting fluorouracil from FOLFIRI plus bevacizumab as second-line chemotherapy for patients with metastatic colorectal cancer.
Matsubara Y, Masuishi T, Ogata T, Nakazawa T, Kato K, Nozawa K, Narita Y, Honda K, Bando H, Taniguchi H, Kadowaki S, Ando M, Tajika M, Muro K. Matsubara Y, et al. Among authors: nozawa k. J Cancer Res Clin Oncol. 2023 Mar;149(3):1123-1129. doi: 10.1007/s00432-022-03979-2. Epub 2022 Mar 22. J Cancer Res Clin Oncol. 2023. PMID: 35314873 Clinical Trial.
The impact of combined PD-L1 positive score on clinical response to nivolumab in patients with advanced esophageal squamous cell carcinoma.
Matsubara Y, Toriyama K, Kadowaki S, Ogata T, Nakazawa T, Kato K, Nozawa K, Narita Y, Honda K, Masuishi T, Bando H, Ando M, Tajika M, Oze I, Hosoda W, Muro K. Matsubara Y, et al. Among authors: nozawa k. Esophagus. 2023 Jul;20(3):524-532. doi: 10.1007/s10388-022-00978-7. Epub 2023 Jan 3. Esophagus. 2023. PMID: 36595124
The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status.
Horisawa N, Adachi Y, Takatsuka D, Nozawa K, Endo Y, Ozaki Y, Sugino K, Kataoka A, Kotani H, Yoshimura A, Hattori M, Sawaki M, Iwata H. Horisawa N, et al. Among authors: nozawa k. Breast Cancer. 2022 Mar;29(2):234-241. doi: 10.1007/s12282-021-01303-3. Epub 2021 Oct 7. Breast Cancer. 2022. PMID: 34622383
Adjuvant Olaparib in BRCA-Mutated Breast Cancer.
Nozawa K, Yoshimura A, Iwata H. Nozawa K, et al. N Engl J Med. 2021 Oct 7;385(15):1439. doi: 10.1056/NEJMc2112373. N Engl J Med. 2021. PMID: 34614336 No abstract available.
431 results